Blessing participates in new cancer treatment trial
The Blessing Cancer Center has been selected as one of 51 study locations worldwide participating in a new metastatic breast cancer clinical trial. Metastatic cancer has traveled to other parts of the body from its site of origination. It is estimated that 20-30 percent of all breast cancer cases will become metastatic. The clinical trial is studying the effectiveness, safety and tolerability of a first-of-its-kind medication, Enobosarm.
read more